PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets
Successful cell targeting depends on the controlled positioning of cell-type-specific antibodies on the nanocarrier’s (NC) surface. Uncontrolled antibody immobilization results in unintended cell uptake due to Fc-mediated cell interaction. Consequently, precise immobilization of the Fc region toward...
Main Authors: | Maximilian Brückner, Michael Fichter, Richard da Costa Marques, Katharina Landfester, Volker Mailänder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/8/1614 |
Similar Items
-
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
by: Jenny Schunke, et al.
Published: (2023-07-01) -
OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells
by: Sebastian Wirsching, et al.
Published: (2022-09-01) -
Multivalency Beats Complexity: A Study on the Cell Uptake of Carbohydrate Functionalized Nanocarriers to Dendritic Cells
by: Matthias Krumb, et al.
Published: (2020-09-01) -
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
by: Shanshan Cheng, et al.
Published: (2020-04-01) -
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
by: Heng Dong, et al.
Published: (2023-06-01)